TOKYO and PALO ALTO, Calif., July 10, 2018 /PRNewswire-USNewswire/ — Otsuka Holdings Co., Ltd. (“Otsuka Holdings”), Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) and ReCor Medical, Inc. (“ReCor”) announce the signing of a merger agreement pursuant to which Otsuka Holdings will acquire the remaining shares in ReCor from its current holders. The transaction is […]
Rhythm
Northwestern Medicine Receives Grant to Lead Research into Atrial Fibrillation and Stroke
CHICAGO, June 29, 2018 /PRNewswire-USNewswire/ — The American Heart Association recently selected Northwestern Medicine as one of six centers to be part of a new, grant-funded national network dedicated to researching and understanding the causes of atrial fibrillation, the most common type of irregular heartbeat. At Northwestern, a $3.7 million grant will fund research specifically on […]
Ministry of Health and Prevention of United Arab Emirates Introduces National Newborn Oncochlear CCHD Program with Masimo Rad-97 ™ Pulse CO Oximeters ® with Eve ™
DUBAI, United Arab Emirates – ( BUSINESS WIRE ) – Masimo (NASDAQ: MASI) today announced that the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) is launching a nationwide screening Protocol for Congenital Heart Disease (CCHD) for all newborns. As part of the launch of the program which equips MOHAP nine clinics in […]
CHLA/USC Researchers Design Novel Micropacemaker
LOS ANGELES–(BUSINESS WIRE)–Investigators at Children’s Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart — a breakthrough that may open up new cardiac pacing options for children and adults. The micropacemaker — inserted through a single, […]
Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced 1-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) registry as reported on Saturday, June 23rd at the 2018 Society for Vascular Surgery Annual Meeting. The LUCY study […]
HeartSciences Showcases MyoVista® Wavelet ECG at the 2018 International Congress on Electrocardiology (ICE)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June 28-30, 2018. ICE2018 will be the joint meeting of the 45th Congress of […]
Novoheart Announces Presentation at the International Society for Stem Cell Research Annual Meeting
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH) is pleased to announce a presentation was delivered on June 22nd, 2018, entitled “Modeling Cardiac Dysfunction of Friedreich’s Ataxia Using Ventricular Sheets, Tissues and Chambers Engineered from Human Pluripotent Stem Cells,” at the Annual Meeting of […]
Caelum Biosciences Announces Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis
NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) — Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced a complete analysis of cardiac data from Columbia University’s (“Columbia”) Phase 1b trial that supports CAEL-101’s (mAb 11-1F4) potential to improve myocardial function as […]
Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement
ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment […]
New Study Demonstrates Accuracy of Fully-Automated Ejection Fraction Calculation Using Bay Labs’ EchoMD AutoEF Software
Study Results Presented at American Society of Echocardiography Annual Scientific Sessions NASHVILLE, Tenn. – June 25, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF deep learning software has less variability in evaluating left ventricular […]



